Nrf2 protects against As(III)-induced damage in mouse liver and bladder
- 16 June 2009
- journal article
- research article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 240 (1), 8-14
- https://doi.org/10.1016/j.taap.2009.06.010
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Dual roles of Nrf2 in cancerPharmacological Research, 2008
- Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis CJournal of Viral Hepatitis, 2008
- Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1–Cul3 interactionToxicology and Applied Pharmacology, 2008
- Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicityToxicology and Applied Pharmacology, 2007
- Chronic arsenic poisoning: a global health issue – a report of multiple primary cancersJournal of Cutaneous Pathology, 2007
- Nrf2 as a target for cancer chemopreventionMutation Research, 2005
- Caffeic acid phenethyl ester (CAPE) prevents transformation of human cells by arsenite (As) and suppresses growth of As-transformed cellsToxicology, 2005
- Arsenic, mode of action at biologically plausible low doses: What are the implications for low dose cancer risk?Toxicology and Applied Pharmacology, 2005
- Skin Cancer and Inorganic Arsenic: Uncertainty‐Status of RiskRisk Analysis, 1997
- DNA methylation and methylase levels in normal and malignant mouse hepatic tissuesCarcinogenesis: Integrative Cancer Research, 1981